Advanced Hepatocellular Carcinoma: Early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results

European Journal of Radiology

Volumn 82, Issue 5, 2013, Pages

  Frampas, Eric ^a   Lassau, Nathalie ^b   Zappa, Magaly ^c   Vullierme, Marie Pierre ^c   Koscielny, Serge ^b   Vilgrain, Valérie ^c,d  

^a HÔTEL DIEU   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c BEAUJON HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Angiogenesis; Computed tomography; Hepatocellular Carcinoma; Perfusion imaging; Targeted therapy; Ultrasonography

Indexed keywords

SORAFENIB; SUNITINIB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; EARLY DIAGNOSIS; FEMALE; HEPATITIS; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INDOLES; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NIACINAMIDE; PERFUSION IMAGING; PHENYLUREA COMPOUNDS; PILOT PROJECTS; PROGNOSIS; PYRROLES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 84875739145     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.12.004     Document Type: Article

References (30)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA: A Cancer Journal for Clinicians 61 2 2011 69 90
2. J.M. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma New England Journal of Medicine 359 4 2008 378 390
3. F. Borie, A.M. Bouvier, and A. Herrero Treatment and prognosis of hepatocellular carcinoma: a population based study in France Journal of Surgical Oncology 98 7 2008 505 509
4. International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia Hepatology 49 2 2009 658 664
5. L. Messerini, L. Novelli, and C.E. Comin Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma Journal of Clinical Pathology 57 8 2004 867 871 (Pubitemid 39061438)
6. G.M. Keating, and A. Santoro Sorafenib: a review of its use in advanced hepatocellular carcinoma Drugs 69 2 2009 223 240
7. I.M. Desar, C.M. van Herpen, H.W. van Laarhoven, J.O. Barentsz, W.J.G. Oyen, and W.T. van der Graaf Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy Cancer Treatment Reviews 35 4 2009 309 321
8. A. Riaz, K. Memon, and F.H. Miller Role of the EASL, RECIST and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation Journal of Hepatology 54 4 2011 695 704
9. A.X. Zhu, N.S. Holalkere, A. Muzikansky, K. Horgan, and D.V. Sahani Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced carcinoma Oncologist 13 2 2008 120 125 (Pubitemid 351342575)
10. N. Lassau, S. Koscielny, and L. Chami Advanced hepatocellular carcinoma: early evaluation of response to Bevacizumab therapy at Dynamic Contrast-enhanced US with quantification-preliminary results Radiology 258 1 2011 291 300
11. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 5 2005 1208 1236 (Pubitemid 43112690)
12. W. Huda, K.M. Ogden, and M.R. Khorasani Converting dose-length product into effective dose Radiology 248 3 2008 995 1003
13. J.A. Johnson, and T.A. Wilson A model for capillary exchange American Journal of Physiology 210 6 1966 1299 1303
14. D.V. Sahani, N.S. Holalkere, P.R. Mueller, and A.X. Zhu Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue - initial experience Radiology 243 3 2007 736 743 (Pubitemid 46799427)
15. H. Choi, C. Charnsangavej, and S.C. Faria Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with Imatinib Mesylate: proposal of new computed tomography response criteria Journal of Clinical Oncology 25 13 2007 1753 1759 (Pubitemid 46797957)
16. A. Forner, C. Ayuso, and M. Varela Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 3 2009 616 623
17. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) European Journal of cancer 45 2 2009 228 247
18. G.K. Abou-Alfa, L. Schwartz, and S. Ricci Phase II study of sorafenib in patients with advanced hepatocellular carcinoma Journal of Clinical Oncology 24 26 2006 4293 4300 (Pubitemid 46630787)
19. A.L. Cheng, Y.K. Kang, and Z. Chen Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomized, double-blind, placebo-controlled trial Lancet Oncology 10 1 2009 25 34
20. V. Goh, S. Halligan, F. Daley, D.M. Wellsted, T. Guenther, and C.I. Bartram Colorectal tumor vascularity: quantitative assessment with multidetector CT - do tumor perfusion measurements reflect angiogenesis? Radiology 249 2 2008 510 517
21. J. Yao, Z.G. Yang, T.W. Chen, Y. Li, and L. Yang Perfusion changes in gastric adenocarcinoma: evaluation with 64-section MDCT Abdominal Imaging 35 2 2010 195 202
22. J. Xu, Z. Liang, and S. Hao Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging Abdominal Imaging 34 6 2009 759 766
23. T.Y. Lee, T.G. Purdie, and E. Stewart CT imaging of angiogenesis Quarterly Journal of Nuclear Medicine 47 3 2003 171 187 (Pubitemid 37279154)
24. H.J. Jiang, H.B. Lu, and Z.R. Zhang Experimental study on angiogenesis in a rabbit VX2 early liver tumour by perfusion computed tomography Journal of International Medical Research 38 3 2010 929 939
25. A. Sabir, R. Schor-Bardach, and C.J. Wilcox Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy American Journal of Roentgenology 191 1 2008 133 139 (Pubitemid 351955217)
26. N. Lassau, V. Vilgrain, and M. Kind Evaluation of anti-angiogenic treatments with DCE-US (dynamic contrast enhanced ultrasonography) in 539 patients European multidisciplinary cancer congress Stockholm, Sweden, ESMO, September 2011
27. M. Gauthier, I. Leguerney, and J. Thalmensi Estimation of intra-operator variability in perfusion parameter measurements using DCE-US World Journal of Radiology 3 3 2011 70 81
28. A. Riaz, F.H. Miller, and L.M. Kulik Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma Journal of the American Medical Association 303 11 2010 1062 1069
29. V. Goh, M. Dattani, and J. Farwell Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis European Radiology 21 5 2011 974 981
30. P.C. Sanelli, G. Nicola, and A.J. Tsiouris Reproductibility of postprocessing of quantitative CT perfusion maps American Journal of Roentgenology 188 1 2007 213 218 (Pubitemid 46012511)